Gotham Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.43M | Buy |
98,968
+55,756
| +129% | +$4.4M | 0.02% | 764 |
|
|
2025
Q4 | $3.42M | Buy |
43,212
+11,060
| +34% | +$833K | 0.01% | 900 |
|
|
2025
Q3 | $2.1M | Buy |
32,152
+17,873
| +125% | +$873K | 0.01% | 986 |
|
|
2025
Q2 | $564K | Buy |
+14,279
| New | +$467K | ﹤0.01% | 1296 |
|
|
2025
Q1 | – | Sell |
-6,260
| Closed | -$219K | – | 1613 |
|
|
2024
Q4 | $219K | Sell |
6,260
-2
| -0% | -$75 | ﹤0.01% | 1341 |
|
|
2024
Q3 | $251K | Hold |
6,262
| – | – | ﹤0.01% | 1286 |
|
|
2024
Q2 | $298K | Sell |
6,262
-524
| -8% | -$21.5K | ﹤0.01% | 1227 |
|
|
2024
Q1 | $294K | Sell |
6,786
-203
| -3% | -$9.68K | ﹤0.01% | 1188 |
|
|
2023
Q4 | $354K | Sell |
6,989
-1,099
| -14% | -$52.6K | 0.01% | 1090 |
|
|
2023
Q3 | $367K | Buy |
8,088
+23
| +0.3% | +$949 | 0.01% | 1051 |
|
|
2023
Q2 | $331K | Sell |
8,065
-5,168
| -39% | -$199K | 0.01% | 1089 |
|
|
2023
Q1 | $473K | Sell |
13,233
-56,663
| -81% | -$2.13M | 0.01% | 983 |
|
|
2022
Q4 | $2.64M | Buy |
69,896
+46,656
| +201% | +$1.96M | 0.07% | 335 |
|
|
2022
Q3 | $1.03M | Sell |
23,240
-38,244
| -62% | -$1.61M | 0.03% | 638 |
|
|
2022
Q2 | $2.28M | Buy |
61,484
+23,057
| +60% | +$869K | 0.07% | 333 |
|
|
2022
Q1 | $1.42M | Buy |
+38,427
| New | +$1.26M | 0.04% | 454 |
|
|
2020
Q2 | – | Sell |
-97,992
| Closed | -$4.63M | – | 1122 |
|
|
2020
Q1 | $4.63M | Buy |
97,992
+43,645
| +80% | +$2.43M | 0.13% | 241 |
|
|
2019
Q4 | $3.28M | Sell |
54,347
-148,409
| -73% | -$8.84M | 0.06% | 354 |
|
|
2019
Q3 | $12.2M | Buy |
202,756
+57,566
| +40% | +$3.75M | 0.21% | 128 |
|
|
2019
Q2 | $9.33M | Buy |
145,190
+133,840
| +1,179% | +$9.46M | 0.15% | 188 |
|
|
2019
Q1 | $921K | Buy |
+11,350
| New | +$732K | 0.01% | 681 |
|
|
2018
Q2 | – | Sell |
-32,409
| Closed | -$1.43M | – | 956 |
|
|
2018
Q1 | $1.43M | Sell |
32,409
-80,668
| -71% | -$4.1M | 0.02% | 553 |
|
|
2017
Q4 | $5.69M | Sell |
113,077
-176,531
| -61% | -$9.68M | 0.08% | 329 |
|
|
2017
Q3 | $14.7M | Sell |
289,608
-67,849
| -19% | -$3.55M | 0.22% | 144 |
|
|
2017
Q2 | $18.2M | Buy |
357,457
+44,025
| +14% | +$2.05M | 0.26% | 124 |
|
|
2017
Q1 | $12.6M | Buy |
313,432
+217,756
| +228% | +$9.78M | 0.16% | 213 |
|
|
2016
Q4 | $4.58M | Buy |
+95,676
| New | +$3.79M | 0.06% | 397 |
|
|
2015
Q4 | – | Sell |
-64,741
| Closed | -$2.62M | – | 923 |
|
|
2015
Q3 | $2.62M | Buy |
64,741
+49,902
| +336% | +$2.58M | 0.03% | 513 |
|
|
2015
Q2 | $854K | Buy |
14,839
+6,947
| +88% | +$442K | 0.01% | 661 |
|
|
2015
Q1 | $502K | Sell |
7,892
-853
| -10% | -$57.9K | ﹤0.01% | 696 |
|
|
2014
Q4 | $540K | Buy |
+8,745
| New | +$432K | ﹤0.01% | 722 |
|
Other funds holding IONS
VPM
VCM
Gotham Asset Management's IONS Position: Q1 2026 in Review
Gotham Asset Management increased its Ionis Pharmaceuticals (IONS) stake by 129% in Q1 2026, buying an estimated $4.4M and bringing the position to 98,968 shares worth $7.43M. The position accounts for 0.02% of the portfolio, ranked #764.
Gotham Asset Management first reported a position in IONS in Q4 2014 and has held it in 31 quarters since. The position peaked at $18.2M in Q2 2017. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Gotham Asset Management held 98,968 shares of Ionis Pharmaceuticals worth $7.43M as of Q1 2026.
- Gotham Asset Management bought 55,756 Ionis Pharmaceuticals shares in Q1 2026, an estimated $4.4M.
- Ionis Pharmaceuticals made up 0.02% of Gotham Asset Management's portfolio in Q1 2026, its #764 holding.
- Gotham Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2014 and has held it in 31 quarters since.
- Gotham Asset Management's Ionis Pharmaceuticals position peaked at $18.2M in Q2 2017.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.